scholarly journals The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France

2019 ◽  
Vol 112 (11) ◽  
pp. 713-722
Author(s):  
Vincent Galand ◽  
Cecilia Linde ◽  
Nicolas Lellouche ◽  
Jacques Mansourati ◽  
Jean-Claude Deharo ◽  
...  
Keyword(s):  
Cardiac Resynchronization Therapy ◽  
European Society ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
European Society Of Cardiology ◽  
Cardiac Resynchronization Therapy Implantation

Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort

2020 ◽  
Vol 21 (9) ◽  
pp. 634-640 ◽  
Author(s):  
Giovanni L. Botto ◽  
Maurizio Gasparini ◽  
Francesco M.A. Brasca ◽  
Maria C. Casale ◽  
Eraldo Occhetta ◽  
...  
Keyword(s):  
Cardiac Resynchronization Therapy ◽  
European Society ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
European Society Of Cardiology ◽  
Italian Cohort

2177Cardiac resynchronization therapy in patients greater than 75 years of age - results from the European Society of Cardiology Survey II with 11 088 patients

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
C Normand ◽  
K Dickstein ◽  
C Linde
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Adverse Events ◽  
Cardiac Resynchronization Therapy ◽  
European Society ◽  
Nyha Class ◽  
Cardiac Resynchronization ◽  
Class Iii ◽  
Resynchronization Therapy ◽  
European Society Of Cardiology

Abstract Background Cardiac Resynchronization Therapy (CRT) reduces morbidity and mortality in selected patients with heart failure (HF) and electrical dyssynchrony. The median age for patients included in the CRT landmark trials ranged from 62–68 years, therefore limited trial evidence exists on CRT in patients ≥75 years of age. Purpose To assess similarities and differences in patient demographics and implantation practice in different age groups implanted with a CRT device. Methods Between 2015 and 2017, two European Society of Cardiology (ESC) associations, European Heath Rhythm Society and the Heart Failure Association, conducted the CRT Survey II, a survey of CRT implantations in 11,088 patients in 42 ESC member states. Results In our survey 32% of patients included were ≥75 years of age. These patients were more frequently in NYHA Class III or IV, had more comorbidity (including hypertension, atrial fibrillation, anaemia and renal dysfunction) and had significantly higher NT-pro BNP levels than younger patients. Slightly fewer patients ≥75 years of age had LBBB but all groups had the same median QRS duration. Despite substantially more patients ≥75 years of age having HF of ischaemic aetiology compared with those <65 year of age, far fewer patients in oldest age group category were implanted with a CRT-defibrillator (CRT-D) compared with those in the youngest group. CRT Survey II Patients by Age Categories Demographics Age <65 years Age 65–74 years Age ≥75 years N 3478 (32%) 4025 (36%) 3536 (32%) NYHA class III & IV 52% 59% 66%* Ischaemic HF aetiology 33% 49% 50%* Atrial fibrillation 17% 27% 33* NT proBNP (pg/ml, median, IQR) 1651 (670, 3811) 2319 (1070, 5169) 3510 (1647, 7631)* CRT-D 81% 76% 52%* Peri-procedural complications 5% 6% 6% Adverse Events during hospitalization 4% 5% 5% CRT-D, Cardiac resynchronization therapy – defibrillator; HF, heart failure; IQR, interquartile range. *Differences between groups is significant with p<0.001. Conclusions Patients ≥75 years of age had greater comorbidity and experienced more symptoms from their heart failure. However, they did not suffer more complications or adverse events during the index hospitalization, suggesting that CRT may safely be offered to elderly patients. Acknowledgement/Funding The work was supported by EHRA, the HFA, Biotronik, Boston Scientific, Medtronic, Sorin, St. Jude, Abbott, Bayer, Bristol-Myers Squibb and Servier

scholarly journals Cardiac resynchronization therapy in Romania – results from the European Society of Cardiology CRT Survey II

2020 ◽  
Vol 30 (1) ◽  
pp. 48-55
Author(s):  
Ioana Sus ◽  
Radu Vatasescu ◽  
Calin Siliste ◽  
Alexandru Deutsch ◽  
Dragos Cozma ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cardiac Resynchronization Therapy ◽  
European Society ◽  
Heart Rhythm ◽  
European Countries ◽  
Cardiac Resynchronization ◽  
Valuable Insight ◽  
Resynchronization Therapy ◽  
European Society Of Cardiology

The European Cardiac Resynchronization Therapy Survey II is the second CRT survey of the Heart Failure Association and European Heart Rhythm Association designed to observe implantation and follow-up practices across European countries. These data allow, for the fi rst time, a valuable insight on CRT implantation strategies for Romanian patients.

Sign in / Sign up

Export Citation Format

Share Document